Bayer AG - Stockholders' Newsletter First Quarter 2009

News in the first quarter 2009

Study shows positive effect of
interferon beta-1b
Early therapy of multiple sclerosis » more

Company strengthens its crop protection portfolio
Bayer CropScience acquires biological products from AgroGreen for the crop protection business » more

New herbicidal active ingredient indaziflam presented
Doing away with weeds » more

Good prospects for the future:
Carbon nanotubes – a key technology » more

2:42 min.

Phase III program launched for active substance riociguat
New substance class to treat pulmonary hypertension » more

CropScience to invest €30 million in Dormagen
Capacity expansion for crop protection products » more

News Overview

Key Data
Bayer Group
Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees » more

Management Report
Overview of Sales, Earnings and Financial Position
The performance of our subgroups in the first quarter of 2009 varied widely as expected. » more

Bayer Stock
Investor Information
The price of Bayer stock was relatively stable from early January to mid-February 2009 within a narrow range from €41.60 to €44.29. » more

Focus
Honoring Energy Efficiency
The Bayer Science & Education Foundation chose energy efficiency expert Professor Eberhard Jochem to receive the first Bayer Climate Award. » more

3:58 min.